Additionally, systemic administration of 140 mg three times daily showed a trend toward reducing chemotherapy-induced hepatotoxicity, further endorsing silybin’s role as a protective adjunct during standard treatments [ 193 , 229 , 230 ]. 7.5.
← all excerpts
Plant Bioactive Constituents and Their Potential Benefits in HPV-Positive Oropharyngeal Squamous Cell Carcinoma—A Narrative Review
1
—
—